Dr. Binh Nguyen retired from FDA in March 2023 after 20 years specializing in pharmaceutical training, compliance, management, and inspectional audits for CDER (Center for Drugs Evaluation and Research) and ORA (Office of Regulatory Affairs).  He was a Level III Certified Pharmaceutical Inspectorate, a Level II Drug Auditor, drug branch chief, and director regulatory review officer for biotech, sterile injectable, sterile compounding, positron emission tomography, combination products, and other dosage forms.  He also worked as a clinical and compounding pharmacist at a UCI Hospital, a 400-bed acute care hospital for 21 years.   He served as a counsel member in sterile compounding pharmacy for the Board of Pharmacy Specialties for 3 years.  He completed his doctorate in pharmacy and master in regulatory science at the University of Southern California.  He is the founder and developer for the global inspection software with AI called ieQip (intelligent electronic Quality inspection platform) which can be used as independent third party or internal audit.  He consulted for Lachman Consultants prior to launching Wynngate Corporation in March 2024.